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PERSONAL DRUG UTILIZATION REPORT (PDUR)—A
CONTRIBUTION TO COST REDUCTION AND PATIENT
EMPOWERMENT
Lentges N,Verheyen F, Hecke TL, Müller H
Techniker Krankenkasse, Hamburg, Germany
OBJECTIVES: The lack of transparency in health care is one of
the major obstacles to ensure rational and cost-effective use of
health care resources. Reduction of costs for drugs is an impor-
tant challenge for the statutory sickness funds in Germany. The
Techniker Krankenkasse (TK) as one of the largest statutory sick-
ness funds pays special attention to this development by offer-
ing an individualized service to their insurees called “Personal
Drug Utilization Report” (PDUR). This service informs patients
about their drug use behaviours and is expected to discuss either
with the physician or the pharmacist. PDUR aims to: 1) Improve
patients’ knowledge about their drug utilization; 2) inﬂuence
their behaviours; 3)contribute to patients’ active participation in
the medical decision process; and 4)strenghthen patients’ com-
pliance. METHODS: Based on pharmacy claims data, the
patients receive their PDUR upon request that comprises all
drugs and medical devices prescribed by a physician and dis-
pensed by community pharmacies. Currently, PDUR covers the
prescription data of the last 24 months and lists following items:
product name, dispensing date, dispensing pharmacies, co-
payments, central pharmaceutical number. RESULTS: PDUR has
found a wide acceptance with the TK insurees: from August,
2003 to May, 2004 50,000 (17.9% of all eligible patients for
this service) asked for their individual PDUR. CONCLUSIONS:
Expanding health-orientated services, elaborating drug informa-
tion systems and strengthening the patient role in the health care
system are of importance for TK. The high grade of acceptance
shows that PDUR ﬁts the patientsx need and expectancies.
PDUR is considered as a ﬁrst module to implement other tools
like an electronic patient dossier and will be supplemented by
other health-related services. In the future, all PDUR will be
accompanied by a satisfaction survey. First results of a health-
economic evaluation are expected for the end of this year.
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WEIGHING DIAGNOSES IN EVALUATION STUDIES WITH AN
APPLICATION TO SYNCOPE
Boer KR,Van Dijk N,Wieling W, Dijkgraaf MGW
Academic Medical Center / University of Amsterdam, Amsterdam,
Netherlands
OBJECTIVES: It is difﬁcult to assess the efﬁciency of diagnostic
strategies without knowledge of the outcome of subsequent
treatment. This is particularly true for strategies that aim to iden-
tify various diagnoses, each of which leading to a different treat-
ment. We propose a methodology for weighing different
diagnoses, illustrated by a diagnostic study of syncope.
METHODS: After listing all diagnoses (n = 27) that might
explain the occurrences of syncope, we ﬁrst applied the reper-
tory grid technique of Kelly’s personal construct theory to a core
group of internists, a neurologist and a cardiologist to produce
assessment criteria that are relevant for the weighing of diag-
noses. Secondly, we invited an extended expert panel of 11 spe-
cialists to score the relevance of each criterion on a 0–10 visual
analogue scale and, subsequently, to rank each diagnosis at each
criterion on a 0–100 scale. The third step consists of calculating
the summed products of the criterion relevance scores and the
diagnosis rank scores at each criterion for each diagnosis sepa-
rately to derive diagnosis speciﬁc weights. RESULTS: The core
specialist group identiﬁed eight criteria for the weighing of
syncope diagnoses. The criteria were, by descending order of rel-
evance: mortality (7.4), treatability (6.6), quality of life (5.8),
prognosis (5.4), frequency of episodes (5.1), presence of presyn-
cope (4.2), treatment costs (3.3), and prevalence (3.0). The most
important diagnoses were secondary (2432) and primary (2407)
autonomic failure syndromes, acute aortic dissection (2266), and
obstructive cardiomyopathy (2156). The least important ones
were hyperventilation with hypocapnia (1296) and volume
depletion (1152). CONCLUSIONS: The presented methodology
succesfully generated diagnosis speciﬁc weights that can be used
for the evaluation of diagnostic strategies during decision mod-
eling. The methodology will further be strenghtened by an expert
panel consensus meeting between the second and third steps to
clarify and minimize score and ranking differences.
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VISUAL ANALOGUE SCALES: ARE THE ELICITED
PREFERENCES ANALOGUE?
Akunne AF, Bridges JFP, Sauerborn R
University of Heidelberg, Heidelberg, Baden-Wuerrtembe, Germany
OBJECTIVES: This study compared the reliability and feasibil-
ity of three different versions of VAS on socioeconomic hetero-
geneous groups in a developing country. METHODS: Ten health
states were described and applied on forty adults with mean age
33. In the ﬁrst version, 10 cubes were placed against health
states, and respondents were requested to remove the number of
cubes equivalent to loss in health associated with the state with
ten cubes equivalent to full health and zero cube equivalent to
death. In the second version, they had the conventional VAS and
were requested to point at the scale. Thirdly, respondents were
requested to pick from a collection of cubes the number equiv-
alent to each health state with ten cubes equal to death and no
cube being equivalent to full health. Mean explanation and 
valuation times were 5 and 18 minutes respectively. Thirteen
percent of the respondents had problems understanding the ﬁrst
version of the instrument. RESULTS: The standard deviation of
the elicited values with the second version was highest for all the
disease cases (Disease: Std{1st, 2nd, 3rd version}; Epilepsy:
Std{0.25, 0.28, 0.23}, Bronchitis: Std{0.20, 0.27, 0.22}, Dental
Pain: Std{0.21, 0.23, 0.18}, Vertigo: Std{0.17, 0.23, 0.17},
Madness: Std{0.29, 0.32, 0.28}, etc). ANOVA procedure showed
that mean scores obtained using the different versions were sta-
tistically different for eight out of the ten diseases (Epilepsy
{<.0003}, Bronchitis {<0.0012}, Dental Pain {<0.0165}, Vertigo
{<0.0001}, Madness {<0.8321}, etc). CONCLUSIONS: In 
comparing the preferences elicited with VAS, caution should 
be exercised as different modiﬁcations of the instrument 
were demonstrated to yield different values. In the elicitation
process, the alternative versions of VAS may have allowed the
incorporation of other values which lacked with the conven-
tional VAS.
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THERE’S NO F IN UTILITY
Kind P
Outcomes Research Group,York, UK
OBJECTIVES: It is generally held that quality-adjustment
weights used to compute QALYs must be elicited using utilities.
This paper challenges that orthodoxy in three ways.
METHODS: Firstly, the legitimacy of cardinal utility measure-
ment itself is questioned. The absence of a single standard
method for eliciting utilities and the divergence of results
obtained by variants of techniques such as Standard Gamble and
Time Trade-Off provides evidence of the non-unique status of
utility measurement. The failure to identify an ex post test of the
status of utility measurement means that it is impossible even to
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test the claim that any set of values are in fact utility weights.
Secondly, quality-adjustment weights play a crucial role in deter-
mining cost-utility ratios. Different weights are elicited when 
different utility measurement techniques are used, so that cost-
utility ratios can be susceptible to systematic bias depending
upon the choice of method used. Examples of this weakness are
provided from the published literature and reveal the extent to
which cost/QALY ratios can vary in the analysis of a single inter-
vention. Finally, the paper argues for a less technically demand-
ing approach to the determination of preferences in the valuation
of health. RESULTS: It speciﬁes the minimum requirements for
any quality-adjustment index and proposes the use of stated pref-
erence methods that have an established theoretical basis but that
are also grounded in the practical day-to-day experiences of ordi-
nary people. The case is demonstrated using VAS data collected
in a UK national postal survey (n = 682) designed to establish
values for EQ-5D health states but where paired comparisons
methods have been used to establish health state values. CON-
CLUSIONS: The paper concludes that there is no basis for the
continued reliance on utility weights in calculating cost/QALY
ratios.
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STATISTICAL ISSUES IN DISCRETE CHOICE MODELLING
Fitzgerald PE1,Aristides M2
1M-TAG Pty Ltd, Chatswood West, New South Wales, Australia;
2M-TAG Ltd, London, UK
Discrete choice models are used to elicit preference data from
patients, medical and allied healthcare experts, and representa-
tive community samples. The resulting data are used in eco-
momic evaluation studies to derive health utility values. In most
reported studies, statistical methodology issues are usually
glossed over and standard assumptions are made. However, sta-
tistical properties of discrete choice models present some inter-
esting challenges to these more traditional views. OBJECTIVES:
In this presentation we focus on two areas fundamental to the
conduct of any discrete choice study: the use of orthogonal
designs in experimental design and interpretation of model
results, and highlight some misconceptions surrounding their
current use. METHODS: More speciﬁcally, we highlight, with
examples, that important properties of orthogonal designs
assumed to underlie methods used in discrete choice studies don’t
hold in general. RESULTS: We also discuss implications of
applying the usual random effects or conditional models to 
discrete choice data. In both cases we discuss alternative
approaches. CONCLUSIONS: The intention of this presentation
is to inform researchers about these potential shortcomings in
statistical methodology which is widely applied to discrete choice
studies, and to encourage the development and use of alterna-
tive methods which may improve validity.
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CHRONIC DISEASE SCORES AMONG SENIORS IN 
ALBERTA, CANADA
Sun J1, Gooch K1, Svenson LW2, Gao S3, Novak K1, Frank C3
1Institute of Health Economics, Edmonton, AB, Canada; 2Alberta
Health and Wellness, Edmonton, AB, Canada; 3University of Calgary,
Calgary, AB, Canada
OBJECTIVES: Derive Chronic Disease Scores (CDS) among
Alberta seniors from population-based automated pharmacy
data. METHODS: Different types of medications prescribed
during 2001/2002 for the treatment and management of chronic
conditions were obtained from Alberta Blue Cross (ABC) claims
database. The medications were clustered into 25 therapeutic
classes to indicate the presence of a chronic illness based on the
criteria proposed by Clark. The study population was composed
of all Alberta residents aged 65 or over who were registered with
the Alberta Health Care Insurance Plan (AHCIP) continuously
from June 30, 2001 to June 30, 2002. Registration with the
AHCIP is mandatory for all Alberta residents. Individuals were
excluded if they had been diagnosed with any malignancy, tuber-
culosis or HIV during the study period. Three outcomes: total
cost, outpatient care cost and the number of primary care visits
in 2002/2003, were derived from AHCIP databases. Linear
regression models were utilized to estimate parameters associ-
ated with age, gender and each medication class for each of the
three outcomes. RESULTS: Records for 221,230 seniors were
used to estimate the empirical weights for calculating CDS. With
the weights an estimate of an individual’s one-year predicted
score for cost and visits can be obtained. For example, a 
72-year-old man receiving medications for rheumatoid 
arthritis would have an estimated one-year total cost of
$2591.96 (3447.66(intercept)+592.62(male)-2868.49(age
65–74)+1420.17(rheumatoid arthritis)). Using the R-square cri-
teria, our CDS prospectively explained 11.9% of the variance in
total cost, 40.7% of outpatient cost, and 10.2% in primary care
visit. These are higher in costs but lower in visits comparing with
Clark’s results. CONCLUSIONS: We estimated CDS with the
same method proposed by Clark using Alberta data. The results
showed that these models can be generally used to measure
disease severity and to predict the prospective health service cost
and utilization for different populations.
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DEVELOPMENT OF A NUTRITION RELATED QUALITY OF
LIFE SCALE IN CHILDREN
Artes M1, Muñoz A1, Cobo JM2, Casas F3, Zaragoza S4, Cáceres M5
1Adelphi Targis, Barcelona, Spain; 2Danone, Barcelona, Spain;
3Universidad de Girona, Girona, Spain; 4Psyncro, Barcelona, Spain;
5Hospital General de Catalunya, Catalunya, Spain
OBJECTIVES: To develop a scale of Nutrition Related Quality
of Life (NRQoL) in healthy children of 6 to 12 years old to be
used in nutritional interventional studies in Spain. METHODS:
The process of development of the DANN scale (Escala DAnone
de calidad de vida relacionada con la Nutrición en Niños/as)
included a literature review to deﬁne potential dimensions, a
qualitative research phase for the elicitation of concepts includ-
ing interviews to clinicians, psychologists, Focus Group with the
target population and expert meetings for the item generation
(version one). The face and content validity was analyzed by
means of a cognitive debrieﬁng process (version two). The quan-
titative research phase consisted of an evaluation of the scale in
125 children followed by a standard item reduction (version 3).
This new version was administered to 500 children from differ-
ent sites in Spain to evaluate the psychometric properties (relia-
bility, construct-related and content-related validity) of the ﬁnal
version. RESULTS: The internal consistency of the DANN self-
administered scale appears satisfactory (Cronbach’s alpha =
0.78). The underlying dimension structure of the scale was con-
ducted by a principal component analysis with varimax rotation.
The three ﬁrst dimensions explained 42% of the total variance
and conceptually corresponded to the dimensions initially
deﬁned (construct-related validity). The ﬁrst dimension gathers
the attitudes and beliefs related with healthy nutrition, consist-
ing of ten items (23%). The second dimension is related to the
physical well-being and includes six items (11%). The third
dimension is related to the psysich well-being and contains three
